|
Synonyms: Neumega®
oprelvekin is an approved drug (FDA (1997))
Compound class:
Peptide
Comment: This is a non-glycosylated, recombinant form of human IL-11 produced in E.coli. Oprelvekin is one amino acid shorter than the endogenous peptide, lacking the amino-terminal proline residue.
|
Classification  |
|
| Compound class | Peptide |
| Approved drug? | Yes (FDA (1997)) |
| International Nonproprietary Names |
|
| INN number | INN |
| 7558 | oprelvekin |
| Synonyms |
| Neumega® |
| Database Links |
|
| ChEMBL Ligand | CHEMBL1201573 |
| DrugBank Ligand | DB00038 |
| GtoPdb PubChem SID | 178103550 |
| Search PubMed clinical trials | oprelvekin |
| Search PubMed titles | oprelvekin |
| Search PubMed titles/abstracts | oprelvekin |
| Wikipedia | Oprelvekin |
